Page last updated: 2024-09-03

parecoxib and Acute Kidney Injury

parecoxib has been researched along with Acute Kidney Injury in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Chen, Q; Guo, Y; Min, S; Wu, B1
Pang, K; Qi, S; Wang, H; Xu, N1
Li, B; Li, D; Liao, Y; Ouyang, W; Qin, Z; Tang, YZ; Zeng, P; Zhang, H1
Barros, GA; Calistro Neto, JP; Domingues, MA; Gonçalves, GM; Módolo, NS; Silva, LM; Torres, Rda C1

Other Studies

4 other study(ies) available for parecoxib and Acute Kidney Injury

ArticleYear
Parecoxib ameliorates renal toxicity and injury in sepsis-induced mouse model and LPS-induced HK-2 cells.
    Drug development research, 2022, Volume: 83, Issue:3

    Topics: Acute Kidney Injury; Animals; Apoptosis; Cyclooxygenase 2; Disease Models, Animal; I-kappa B Kinase; Inflammation; Isoxazoles; Lipopolysaccharides; Mice; NF-kappa B; Sepsis

2022
Correlation between perioperative parecoxib use and postoperative acute kidney injury in patients undergoing radical mastectomy: a retrospective cohort analysis.
    BMC anesthesiology, 2022, 05-20, Volume: 22, Issue:1

    Topics: Acute Kidney Injury; Anti-Inflammatory Agents, Non-Steroidal; Breast Neoplasms; Cohort Studies; Female; Humans; Incidence; Isoxazoles; Mastectomy; Mastectomy, Radical; Postoperative Complications; Retrospective Studies; Risk Factors

2022
Correlation between perioperative parecoxib use and postoperative acute kidney injury in patients undergoing non-cardiac surgery: a retrospective cohort analysis.
    BMJ open, 2021, 08-25, Volume: 11, Issue:8

    Topics: Acute Kidney Injury; Adult; Cohort Studies; Humans; Isoxazoles; Postoperative Complications; Retrospective Studies; Risk Factors

2021
Parecoxib reduces renal injury in an ischemia/reperfusion model in rats.
    Acta cirurgica brasileira, 2015, Volume: 30, Issue:4

    Topics: Acute Kidney Injury; Acute-Phase Proteins; Animals; Biomarkers; Blood Pressure; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Isoxazoles; Kidney; Lipocalin-2; Lipocalins; Male; Prospective Studies; Proto-Oncogene Proteins; Random Allocation; Rats, Wistar; Reperfusion Injury; Reproducibility of Results; Severity of Illness Index; Time Factors; Treatment Outcome

2015